A detailed history of Wakefield Asset Management Lllp transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Wakefield Asset Management Lllp holds 13,819 shares of ANIP stock, worth $842,959. This represents 0.28% of its overall portfolio holdings.

Number of Shares
13,819
Previous 13,986 1.19%
Holding current value
$842,959
Previous $890,000 7.42%
% of portfolio
0.28%
Previous 0.33%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$54.33 - $65.72 $9,073 - $10,975
-167 Reduced 1.19%
13,819 $824,000
Q2 2024

Aug 05, 2024

SELL
$58.53 - $68.82 $10,359 - $12,181
-177 Reduced 1.25%
13,986 $890,000
Q1 2024

May 01, 2024

BUY
$54.2 - $69.69 $767,634 - $987,019
14,163 New
14,163 $979,000
Q3 2023

Nov 01, 2023

SELL
$50.28 - $64.61 $257,685 - $331,126
-5,125 Reduced 29.33%
12,350 $717,000
Q2 2023

Jul 31, 2023

BUY
$37.29 - $53.83 $651,642 - $940,679
17,475 New
17,475 $940,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $1.06B
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Wakefield Asset Management Lllp Portfolio

Follow Wakefield Asset Management Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wakefield Asset Management Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Wakefield Asset Management Lllp with notifications on news.